Clinical Trial Update: Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two taper schedules for buprenorphine/naloxone (Suboxone) in individuals with opioid use disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Opioid-Related Disorders | Phase 3 | Status: COMPLETED